Although the threat of antibiotic resistance is well-documented, global use has increased by 39% between 2000 and 2015, especially in low-income and middle-income countries (LMICs) including South Africa.
A new study by the Center for Disease Dynamics, Economics & Policy (CDDEP), Princeton University, ETH Zurich and the University ……
Continue reading…
Mia Malan answers six important questions about the HIV prevention pill in three minutes.
Continue reading…
NAIROBI – The generic version of the most advanced drug against HIV has been introduced in Kenya, a first in Africa where more than 25m have the disease, the NGO Unitaid said. The drug, Dolutegravir (DTG) is the anti-retroviral drug of choice for those living with HIV in developed countries, but its high price has […]
Continue reading…